omeprazole and irsogladine

omeprazole has been researched along with irsogladine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kitazawa, S; Kyoi, T; Tajima, K; Ukai, Y; Zhang, X	1
Abe, Y; Higuchi, K; Inoue, T; Ishida, K; Kawakami, K; Kojima, Y; Kuramoto, T; Murano, M; Narabayashi, K; Nouda, S; Takeuchi, T; Tokioka, S; Umegaki, E; Yoda, Y	1
Amagase, K; Satoh, H; Takeuchi, K	1

Trials

1 trial(s) available for omeprazole and irsogladine

Article	Year
Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study. BMC gastroenterology, 2013, May-14, Volume: 13 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Endoscopy, Gastrointestinal; Esophagitis; Feces; Female; Humans; Intestinal Mucosa; Intestine, Small; Leukocyte L1 Antigen Complex; Male; Occult Blood; Omeprazole; Peptic Ulcer; Triazines; Young Adult	2013

Article

Year

Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.

BMC gastroenterology, 2013, May-14, Volume: 13

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Endoscopy, Gastrointestinal; Esophagitis; Feces; Female; Humans; Intestinal Mucosa; Intestine, Small; Leukocyte L1 Antigen Complex; Male; Occult Blood; Omeprazole; Peptic Ulcer; Triazines; Young Adult

2013

Other Studies

2 other study(ies) available for omeprazole and irsogladine

Article	Year
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats. Journal of pharmacological sciences, 2004, Volume: 95, Issue:3 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-Ulcer Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Gastric Mucosa; Male; Omeprazole; Peroxidase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rolipram; Stomach Ulcer; Triazines; Tumor Necrosis Factor-alpha	2004
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 348, Issue:2 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines	2014

Article

Year

Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.

Journal of pharmacological sciences, 2004, Volume: 95, Issue:3

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-Ulcer Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Gastric Mucosa; Male; Omeprazole; Peroxidase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rolipram; Stomach Ulcer; Triazines; Tumor Necrosis Factor-alpha

2004

Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.

The Journal of pharmacology and experimental therapeutics, 2014, Volume: 348, Issue:2

Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines

2014